For clinic owners, physicians, and med spa operators, the Certificate of Analysis (COA) is the single most important document you will never show a patient. It sits behind every peptide you stock, and it is the difference between a defensible, compliance-aware practice and one exposed to regulatory, clinical, and reputational risk. Yet many practitioners accept COAs at face value — or don't request them at all.
This guide breaks down exactly how to read a peptide COA, what each section actually means, and where the red flags hide. Whether you run a metabolic clinic, a regenerative medicine practice, or a med spa adding peptide protocols to differentiate your offering, understanding these documents protects your license, your patients, and your bottom line.
Why the COA Matters at the Practice Level
Patient demand for peptide therapies has surged, and with it, a flood of suppliers of wildly varying quality. Published analytical surveys of compounded and research-grade peptides have repeatedly found products that fail to match label claims — under-dosed, contaminated, or containing degraded material. For a consumer, that's a bad purchase. For a clinic, it's a liability event.
Consider the stakes:
- Compliance risk: Sourcing peptides without documented purity and identity leaves you unable to demonstrate due diligence if a regulator or malpractice review ever asks how you verified what you administered.
- Patient safety: Endotoxin contamination and residual synthesis byproducts can drive adverse reactions that damage trust and invite complaints.
- Clinical outcomes: An under-potent peptide produces inconsistent results, undermining the very protocols you built your reputation on.
- Revenue and differentiation: Practices that can confidently speak to sourcing and quality win referrals and command premium pricing.
The COA is your evidence file. Learning to read it well is a core competency, not a back-office formality.
What a Certificate of Analysis Actually Is
A COA is a document issued by the manufacturer (ideally backed by third-party or independent lab testing) that reports the analytical results for a specific batch or lot of a peptide. The key word is batch-specific. A generic COA that isn't tied to the exact lot number on your vial tells you nothing about the product in your hands.
A legitimate COA should always include, at minimum:
- Product name and full amino acid sequence
- Batch or lot number matching the physical product
- Manufacture and test dates
- Purity percentage with the analytical method used
- Identity confirmation (typically mass spectrometry)
- Physical description and net peptide content
- Testing for contaminants where relevant
If any of these are missing, treat the document as incomplete — and ask why.
Reading the Purity Section: HPLC Is the Standard
Purity is the headline number, and it is almost always determined by High-Performance Liquid Chromatography (HPLC). HPLC separates the components of a sample and quantifies them, expressing purity as a percentage of the total. Reverse-phase HPLC is the industry workhorse for peptides.
What percentage should you look for?
For research and clinical-grade peptides, purity of 98% or higher is a reasonable expectation, with many high-quality products reaching 99%+. Anything below 95% warrants scrutiny — the remaining 2–5% consists of related impurities, deletion sequences, truncated fragments, and synthesis byproducts. Some of these impurities are pharmacologically inert; others may compete at receptors or trigger immune responses.
Look for the chromatogram, not just the number
A trustworthy COA includes the actual HPLC chromatogram — a graph showing peaks. The main peptide should appear as a single dominant, sharp peak. A cluster of smaller peaks nearby signals impurities. Be wary of COAs that report a purity percentage with no accompanying chromatogram; the number alone is unverifiable. Also confirm the method details: column type, gradient, and detection wavelength should be documented for a defensible result.
Confirming Identity: Mass Spectrometry
Purity tells you how much of the sample is a single compound. It does not tell you that compound is the peptide you ordered. That's the job of mass spectrometry (MS), usually ESI-MS or MALDI-TOF.
Mass spec measures the molecular weight of the peptide. The COA should list both the theoretical (expected) molecular weight and the observed molecular weight. These should match closely — within the expected error for the instrument. A significant discrepancy means the product may be misidentified, incorrectly synthesized, or degraded. For any peptide you're administering, matching MS data is non-negotiable.
Cross-check the sequence
The COA should state the full amino acid sequence. Match it against the published sequence for that peptide. This catches ordering errors and substitution issues before they reach a patient.
Contaminant and Safety Testing
Beyond purity and identity, several contaminant tests separate pharmaceutical-minded manufacturing from casual supply.
| Test | What It Detects | Why It Matters |
|---|---|---|
| Endotoxin (LAL test) | Bacterial endotoxins / pyrogens | Contamination can cause fever and inflammatory reactions on injection |
| Sterility | Microbial growth | Critical for any injectable preparation |
| Residual solvents | Solvents left from synthesis (e.g., TFA, acetonitrile) | Excess residuals raise toxicity and tolerability concerns |
| Water / moisture content | Free water in lyophilized powder | High moisture accelerates degradation and shortens shelf life |
| Net peptide content | Actual peptide mass vs. total powder | Salt and water can inflate weight — you may be dosing less than labeled |
The net peptide content trap
This one deserves emphasis. A vial labeled 10 mg may contain 10 mg of powder, but only 8 mg of actual peptide once you subtract counter-ions (like acetate or TFA salts) and residual water. Net peptide content — sometimes called peptide content or assay — reveals the true active amount. Two suppliers can both claim 98% purity while delivering meaningfully different doses. For clinics standardizing protocols, this directly affects reproducibility and outcomes.
Red Flags on a Peptide COA
Train yourself and your staff to spot these warning signs:
- No lot number or a lot number that doesn't match the vial
- Purity claim with no chromatogram to support it
- Missing mass spec data or absent theoretical-vs-observed comparison
- No test dates, or dates that predate the manufacture date
- Generic template reused across products with identical values
- No net peptide content reported for a product you plan to dose precisely
- Illegible or low-resolution documents that can't be independently reviewed
- Reluctance to provide a COA at all — the clearest red flag of them all
Building COA Review Into Your Sourcing Workflow
Reading a COA well is only useful if it's systematic. Practical steps for a compliance-aware practice:
- Require a batch-specific COA for every lot you receive — not just the first order.
- Verify the lot number on the document against the physical vial at intake.
- Keep COAs on file alongside your inventory records for the life of the product plus a defensible retention period.
- Prefer third-party verification. Independent lab testing adds credibility beyond in-house manufacturer claims.
- Document your review. A simple checklist showing you evaluated purity, identity, and contaminants demonstrates due diligence.
This workflow costs minutes per shipment and pays dividends if your sourcing is ever questioned.
Quality and Purity Standards: The Non-Negotiables
The peptide market rewards suppliers who treat manufacturing seriously and penalizes those who don't — usually at the patient's expense. As a practice owner, your standard should be uncompromising because you are the last line of accountability before a compound enters a patient.
Insist on partners who manufacture in alignment with FDA guidelines and current Good Manufacturing Practice (cGMP) principles. cGMP isn't a marketing phrase; it's a framework for consistency, documentation, contamination control, and traceability. When a supplier operates this way, the COA you receive is the natural output of a disciplined process rather than a document produced to satisfy a request.
Your minimum quality bar should include:
- HPLC-verified purity at 98%+ with a visible chromatogram
- Mass spectrometry identity confirmation with matching theoretical and observed weights
- Reported net peptide content so your dosing is accurate
- Endotoxin and sterility testing for injectable products
- Batch-specific, third-party-supported documentation you can archive and defend
At Golden Lotus Labs, this is the foundation of how we serve med spas, metabolic clinics, functional-medicine physicians, and regenerative medicine practices. Following FDA guidelines and cGMP practices isn't a differentiator we advertise — it's the baseline we build every batch on, so the practitioners who trust us can build their reputations on solid ground.
The COA is more than paperwork. It's the evidence that what you administer is exactly what you intend, at the potency you expect, free of what shouldn't be there. Learn to read it, demand it every time, and partner only with manufacturers who welcome the scrutiny. Your patients — and your practice — depend on it.